Screening cell kit for antibody identification Panel cells

Antibody identification is used to determine the specificity of antibodies against red blood cell antigens. These antibodies may have clinical significance as they can cause red blood cell destruction as result of transfusion reactions, hemolytic disease of the fetus and newborn or autoimmune hemolytic anemia. With samples that contain multiple antibody specificities or exhibit weak reactivity, it may be necessary to use additional test methods to identify the antibody specificity(ies). The use of enzyme-treated red blood cells is one of the primary means by which antibody differentiation and recognition can be accomplished. Identification of antibodies using supplementary IH-Panel 11 Papain should be considered an adjunct test and not be used as the primary test.